The efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages

Vaccine

Volumn 28, Issue 47, 2010, Pages 7542-7550

  Fabrizio, Kevin ^a   Manix, Catherine ^a   Tian, Haijun ^a   van Rooijen, Nico ^b   Pirofski, Liise anne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Macrophages; Mouse models of pneumococcal disease; Neutrophils; Non opsonic antibodies; Opsonic antibodies; Phagocytes; Pneumococcal capsular polysaccharide; Pneumococcal capsular polysaccharide antibodies; Pneumococcal sepsis; Serotype 3 pneumococcus

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; INTERLEUKIN 6; MONOCLONAL ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; COLONY FORMING UNIT; CONTROLLED STUDY; LEUKOCYTE COUNT; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SURVIVAL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BACTERIAL LOAD; CYTOKINES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; PNEUMOCOCCAL INFECTIONS; POLYSACCHARIDES, BACTERIAL;

EID: 77958197452     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.08.061     Document Type: Article

References (51)

1. Martinez J.E., Romero-Steiner S., Pilishvili T., Barnard S., Schinsky J., Goldblatt D., et al. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin Diag Lab Immunol 1999, 6:581-586.
2. Romero-Steiner S., Frasch C.E., Carlone G., Fleck R.A., Goldblatt D., Nahm M.H. Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin Vaccine Immunol 2006, 13(February (2)):165-169.
3. Martinez J.E., Clutterbuck E.A., Li H., Romero-Steiner S., Carlone G.M. Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae. Clin Vaccine Immunol 2006, 13(April (4)):459-466.
4. Romero-Steiner S., Libutti D., Pais L.B., Dykes J., Anderson P., Whitin J.C., et al. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol 1997, 4:415-422.
5. Burns T., Abadi M., Pirofski L. Modulation of the lung inflammatory response to serotype 8 pneumococcus infection by a human monoclonal IgM to serotype 8 capsular polysaccharide. Infect Immun 2005, 73:4530-4538.
6. Tian H., Weber S., Thorkildson P., Kozel T.R., Pirofski L.A. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice. Infect Immun 2009, 77(April (4)):1502-1513.
7. Chang Q., Zhong Z., Lees A., Pekna M., Pirofski L. Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci. Infect Immun 2002, 70(September (9)):4977-4986.
8. Guy B., Testart C., Gimenez S., Sanchez V., Lheritier P., Rossin D., et al. Comparison of polymorphonuclear cells from healthy donors and differentiated HL-60 cells as phagocytes in an opsonophagocytic assay using antigen-coated fluorescent beads. Clin Diagn Lab Immunol 2000, 7(March (2)):314-317.
9. Sun K., Salmon S.L., Lotz S.A., Metzger D.W. Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect Immun 2007, 75(March (3)):1196-1202.
10. Kadioglu A., Andrew P.W. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol 2004, 25(March (3)):143-149.
11. Marks M., Burns T., Abadi M., Seyoum B., Thornton J., Tuomanen E., et al. Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice. Infect Immun 2007, 75(April (4)):1586-1597.
12. Wang E., Simard M., Ouellet N., Bergeron Y., Beauchamp D., Bergeron M.G. Pathogenesis of pneumococcal pneumonia in cyclophosphamide-induced leukopenia in mice. Infect Immun 2002, 70(August (8)):4226-4238.
13. Zhang Z., Clarke T.B., Weiser J.N. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009, 119(July (7)):1899-1909.
14. Knapp S., Leemans J.C., Florquin S., Branger J., Maris N.A., Pater J., et al. Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med 2003, 167(January (2)):171-179.
15. Shao X., Mednick A., Alvarez M., van R.N., Casadevall A., Goldman D.L. An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. J Immunol 2005, 175(September (5)):3244-3251.
16. Leemans J.C., Juffermans N.P., Florquin S., van Rooijen N., Vervoordeldonk M.J., Verbon A., et al. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol 2001, 166(April (7)):4604-4611.
17. Cote C.K., Rea K.M., Norris S.L., van R.N., Welkos S.L. The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb Pathog 2004, 37(October (4)):169-175.
18. Leendertse M., Willems R.J., Giebelen I.A., Roelofs J.J., van Rooijen N., Bonten M.J., et al. Peritoneal macrophages are important for the early containment of Enterococcus faecium peritonitis in mice. Innate Immun 2009, 15(February (1)):3-12.
19. Fabrizio K., Groner A., Boes M., Pirofski L.A. A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infection. Clin Vaccine Immunol 2007, 14(April (4)):382-390.
20. Fabrizio K., Manix C., Guimaraes A., Nosanchuk J.D., Pirofski L.A. Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo. Clin Vaccine Immunol 2010 March.
21. Briles D.E., Nahm M., Schroer K., Davie J., Baker P., Kearney J., et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med 1981, 153:694-705.
22. Li J., Szalai A.J., Hollingshead S.K., Nahm M.H., Briles D.E. Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages. Infect Immun 2009, 77(January (1)):464-471.
23. Ferreira D.M., Darrieux M., Silva D.A., Leite L.C., Ferreira J.M., Ho P.L., et al. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin Vaccine Immunol 2009, 16(May (5)):636-645.
24. Neeleman C., Geelen S.P., Aerts P.C., Daha M.R., Mollnes T.E., Roord J.J., et al. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect Immun 1999, 67(September (9)):4517-4524.
25. Sullivan M.C., Cooper B.W., Nightingale C.H., Quintiliani R., Lawlor M.T. Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrob Agents Chemother 1993, 37(February (2)):234-239.
26. Briles D.E., Claflin J.L., Schroer K., Forman C., Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae. Nature 1981, 294:88-90.
27. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11(October (4)):443-451.
28. Fabrizio K., Manix C., Guimaraes A.J., Nosanchuk J.D., Pirofski L.A. Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo. Clin Vaccine Immunol 2010, 17(May (5)):713-721.
29. Ajuebor M.N., Das A.M., Virag L., Flower R.J., Szabo C., Perretti M. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 1999, 162(February (3)):1685-1691.
30. van Rooijen N., Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994, 174(September (1-2)):83-93.
31. Stephens-Romero S.D., Mednick A.J., Feldmesser M. The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun 2005, 73(January (1)):114-125.
32. Helmy K.Y., Katschke K.J., Gorgani N.N., Kljavin N.M., Elliott J.M., Diehl L., et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006, 124(March (5)):915-927.
33. Tian H., Groner A., Boes M., Pirofski L. Pneumococcal capsular polysaccharide vaccine-mediated protection of immunodeficient mice against serotype 3 Streptococcus pneumoniae. Infect Immun 2007, 75:1643-1650.
34. Orihuela C.J., Gao G., McGee M., Yu J., Francis K.P., Tuomanen E. Organ-specific models of Streptococcus pneumoniae disease. Scand J Infect Dis 2003, 35(9):647-652.
35. Clatworthy M.R., Smith K.G. FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med 2004, 199(March (5)):717-723.
36. Leendertse M., Willems R.J., Giebelen I.A., Roelofs J.J., Bonten M.J., van der Poll T. Neutrophils are essential for rapid clearance of Enterococcus faecium in mice. Infect Immun 2009, 77(January (1)):485-491.
37. Matthias K.A., Roche A.M., Standish A.J., Shchepetov M., Weiser J.N. Neutrophil-toxin interactions promote antigen delivery and mucosal clearance of Streptococcus pneumoniae. J Immunol 2008, 180(May (9)):6246-6254.
38. Leendertse M., Willems R.J., Giebelen I.A., van den Pangaart P.S., Wiersinga W.J., de Vos A.F., et al. TLR2-dependent MyD88 signaling contributes to early host defense in murine Enterococcus faecium peritonitis. J Immunol 2008, 180(April (7)):4865-4874.
39. Knapp S., Wieland C.W., van 't Veer C., Takeuchi O., Akira S., Florquin S., et al. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol 2004, 172(March (5)):3132-3138.
40. Ghumra A., Shi J., Mcintosh R.S., Rasmussen I.B., Braathen R., Johansen F.E., et al. Structural requirements for the interaction of human IgM and IgA with the human Fcalpha/mu receptor. Eur J Immunol 2009, 39(April (4)):1147-1156.
41. Kikuno K., Kang D.W., Tahara K., Torii I., Kubagawa H.M., Ho K.J., et al. Unusual biochemical features and follicular dendritic cell expression of human Fcalpha/mu receptor. Eur J Immunol 2007, 37(December (12)):3540-3550.
42. Shibuya A., Sakamoto N., Shimizu Y., Shibuya K., Osawa M., Hiroyama T., et al. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol 2000, 1(November (5)):441-446.
43. Li J., Wang J.P., Ghiran I., Cerny A., Szalai A.J., Briles D.E., et al. CR1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence. Infect Immun 2010 May.
44. Repik A., Pincus S.E., Ghiran I., Nicholson-Weller A., Asher D.R., Cerny A.M., et al. A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1). Clin Exp Immunol 2005, 140(May (2)):230-240.
45. Brown E.J., Hosea S.W., Frank M.M. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream. Rev Infect Dis 1983, 5(September (Suppl. 4)):S797-S805.
46. Hosea S.W., Brown E.J., Frank M.M. The critical role of complement in experimental pneumococcal sepsis. J Infect Dis 1980, 142:903-909.
47. Wiesmann C., Katschke K.J., Yin J., Helmy K.Y., Steffek M., Fairbrother W.J., et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 2006, 444(November (7116)):217-220.
48. He J.Q., Wiesmann C., van Lookeren C.M. A role of macrophage complement receptor CRIg in immune clearance and inflammation. Mol Immunol 2008, 45(October (16)):4041-4047.
49. Chen J., Crispin J.C., Dalle L.J., Tsokos G.C. A novel inhibitor of the alternative pathway of complement attenuates intestinal ischemia/reperfusion-induced injury. J Surg Res 2009 June.
50. Vogt L., Schmitz N., Kurrer M.O., Bauer M., Hinton H.I., Behnke S., et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J Clin Invest 2006, 116(October (10)):2817-2826.
51. Katschke K.J., Helmy K.Y., Steffek M., Xi H., Yin J., Lee W.P., et al. A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis. J Exp Med 2007, 204(June (6)):1319-1325.